Wilmington, DE, United States of America

Tasir Haque


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: An Overview of Inventor Tasir Haque

Introduction

Tasir Haque is an accomplished inventor based in Wilmington, DE, who has made significant contributions to the field of neurodegenerative disorders. With one patent to his name, he is recognized for his innovative approaches to treating debilitating conditions that affect cognitive functions.

Latest Patents

Haque's notable patent, titled "Methods for treating neurodegenerative disorders using aspartyl protease inhibitors," encompasses various methods to handle the processing of amyloid precursor protein (APP) and tau protein. The invention emphasizes non-peptide aspartyl protease inhibitors and outlines techniques for addressing neurodegenerative diseases by modulating protein processing. This groundbreaking patent showcases his dedication to advancing medical science and improving patient outcomes.

Career Highlights

Tasir Haque is affiliated with the University of California, where he leverages his expertise to contribute to research and development in the field of neurobiology. His work is pivotal in exploring methods that may offer relief and treatment options for individuals suffering from neurodegenerative ailments.

Collaborations

Throughout his career, Haque has had the opportunity to collaborate with esteemed professionals such as Jonathan A. Ellman and Gary S. Lynch. These collaborations have fostered an environment of shared knowledge and innovation, further enriching the research landscape in which Haque operates.

Conclusion

Tasir Haque stands as a prominent figure in the realm of neurodegenerative research, with a focus on innovative treatments that could alter the course of such diseases. His contributions, particularly through his patent, underscore the importance of continued exploration and innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…